Challenges Loom for FDA Nominee Amid Estrogen Patch Shortages
By Editor • August 21, 2026 • 1 min read
Heidi Overton's FDA nomination is at risk due to her Trump ties, while estrogen patch shortages escalate amid increased demand.
Read moreBy Editor • August 21, 2026 • 1 min read
Heidi Overton's FDA nomination is at risk due to her Trump ties, while estrogen patch shortages escalate amid increased demand.
Read moreBy Editor • August 20, 2026 • 1 min read
Heidi Overton has been nominated for the FDA commissioner role after Kyle Diamantas declined the permanent position.
Read moreBy Editor • August 19, 2026 • 1 min read
Trump has nominated Heidi Overton, a key health policymaker, to lead the FDA, praising her as a vital contributor to his administration's health agenda.
Read moreBy Editor • August 19, 2026 • 1 min read
Heidi Overton is set to be nominated as FDA commissioner, while a new mRNA cancer vaccine shows promise in treating melanoma.
Read moreBy Editor • August 19, 2026 • 1 min read
Heidi Overton is expected to be nominated by Trump as the next FDA commissioner, facing Senate scrutiny prior to her appointment.
Read more